Will Experimental Drugs Be Allowed for Hep C Outbreak Victims? | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Metabolic Health a Priority for Hep C Liver Transplant Recipients

Back to News Homepage
Next

Interferon-Free Treatments Are Imminent for Hep C

Will Experimental Drugs Be Allowed for Hep C Outbreak Victims?

The Editors at Hepatitis Central
July 2, 2012

Print this page

A New Hampshire hospital at fault in a Hepatitis C outbreak is trying to arrange a unique opportunity for those wrongly infected – interferon-free treatment that is still in clinical trials.

Expert: New treatments for hepatitis C patients

By Aaron Sanborn

June 27, 2012

EXETER — A nationally recognized hepatitis C expert from Massachusetts General Hospital told patients infected in the Exeter Hospital hepatitis C outbreak that they may have the option of receiving some cutting edge medication that could treat the infection with few complications.

Dr. Raymond Chung, medical director of the liver transplant program at Massachusetts General Hospital, was the main speaker at a special hepatitis C information night Tuesday at Town Hall. About 100 people attended the meeting hosted by state Rep. Lee Quandt and recently formed patient-advocacy group The Patients Speak.

Chung told the crowd he has been in talks with developers of a new oral treatment for the virus, and they have expressed interest in applying for a “compassion use waiver” with the Food and Drug Administration to use the new treatment exclusively on patients infected in the Exeter Hospital outbreak.

Continue reading this entire article:
http://www.seacoastonline.com/articles/20120627-NEWS-120629837

4 Comments
Share
Share
Previous

Metabolic Health a Priority for Hep C Liver Transplant Recipients

Back to News Homepage
Next

Interferon-Free Treatments Are Imminent for Hep C

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.